MAPT and neurodegenerative disease: To date, more than fifty genetic variants in the MAPT gene have been identified, a significant proportion of which have been associated with the development of neurodegenerative diseases and have been shown to affect tau aggregation, the ratio of its isoforms (3R and 4R), tau binding to microtubules, and involvement in their assembly [4,5,6,7].